Pubblicazioni ufficiali Valneva

Azioni

Mercato chiuso - Euronext Paris Altri mercati azionari 17:38:42 30/04/2024			Dopo chiusura 18:13:14
3,38 ^EUR	-2,48%		3,348	-0,95%

26/03	Valneva avvia una sperimentazione di fase iniziale per il candidato vaccino Zika	MT
26/03	Valneva SE avvia la sperimentazione di Fase 1 del candidato vaccino Zika di seconda generazione	CI

Threshold crossings	11/04	CO
Monthly statement on voting rights	31/03	CO
Monthly statement on voting rights	31/03	CO
Annual ESG Report	27/03	CO
SEC Filing 20 F	25/03	CO
Universal registration document	25/03	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	21/03	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	20/03	CO
Annual results	20/03	CO
Annual results	20/03	CO
Financial report	20/03	CO
Financial report	20/03	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	19/03	CO
Threshold crossings	04/03	CO
Monthly statement on voting rights	29/02	CO
Monthly statement on voting rights	29/02	CO
Monthly statement on voting rights	31/01	CO
Monthly statement on voting rights	31/01	CO
Threshold crossings	16/01	CO
Threshold crossings	15/01	CO
Threshold crossings	14/01	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	31/12	CO
Changes in management and corporate officers	20/12	CO
Changes in management and corporate officers	20/12	CO